381 related articles for article (PubMed ID: 18284193)
1. Conformer distribution in (cis-1,4-DACH)bis(guanosine-5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin.
Ranaldo R; Margiotta N; Intini FP; Pacifico C; Natile G
Inorg Chem; 2008 Apr; 47(7):2820-30. PubMed ID: 18284193
[TBL] [Abstract][Full Text] [Related]
2. X-ray structure and circular dichroism of pure rotamers of bis[guanosine-5'-monophosphate(-1)](N,N,N',N'-tetramethylcyclohexyl-1,2-diamine)platinum(II) complexes that have R,R and S,S configurations at the asymmetric diamine.
Benedetti M; Tamasi G; Cini R; Natile G
Chemistry; 2003 Dec; 9(24):6122-32. PubMed ID: 14679524
[TBL] [Abstract][Full Text] [Related]
3. The first pure LambdaHT rotamer of a complex with a cis-[metal(nucleotide)2] unit: a cis-[Pt(amine)2(nucleotide)2] LambdaHT rotamer with unique molecular structural features.
Benedetti M; Tamasi G; Cini R; Marzilli LG; Natile G
Chemistry; 2007; 13(11):3131-42. PubMed ID: 17225220
[TBL] [Abstract][Full Text] [Related]
4. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
5. Basic coordination chemistry relevant to DNA adducts formed by the cisplatin anticancer drug. NMR studies on compounds with sterically crowded chiral ligands.
Saad JS; Benedetti M; Natile G; Marzilli LG
Inorg Chem; 2010 Jun; 49(12):5573-83. PubMed ID: 20496875
[TBL] [Abstract][Full Text] [Related]
6. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
7. Analysis of platinum adducts with DNA nucleotides and nucleosides by capillary electrophoresis coupled to ESI-MS: indications of guanosine 5'-monophosphate O6-N7 chelation.
Warnke U; Rappel C; Meier H; Kloft C; Galanski M; Hartinger CG; Keppler BK; Jaehde U
Chembiochem; 2004 Nov; 5(11):1543-9. PubMed ID: 15515088
[TBL] [Abstract][Full Text] [Related]
8. DNA fragment conformations in adducts with Kiteplatin.
Margiotta N; Petruzzella E; Platts JA; Mutter ST; Deeth RJ; Ranaldo R; Papadia P; Marzilli PA; Marzilli LG; Hoeschele JD; Natile G
Dalton Trans; 2015 Feb; 44(8):3544-56. PubMed ID: 25144401
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic and kinetic studies on reactions of Pt(II) complexes with biologically relevant nucleophiles.
Summa N; Schiessl W; Puchta R; van Eikema Hommes N; van Eldik R
Inorg Chem; 2006 Apr; 45(7):2948-59. PubMed ID: 16562950
[TBL] [Abstract][Full Text] [Related]
10. Neglected bidentate sp2 N-donor carrier ligands with triazine nitrogen lone pairs: platinum complexes retromodeling cisplatin guanine nucleobase adducts.
Maheshwari V; Marzilli PA; Marzilli LG
Inorg Chem; 2008 Oct; 47(20):9303-13. PubMed ID: 18800828
[TBL] [Abstract][Full Text] [Related]
11. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
Mauldin SK; Husain I; Sancar A; Chaney SG
Cancer Res; 1986 Jun; 46(6):2876-82. PubMed ID: 3698013
[TBL] [Abstract][Full Text] [Related]
12. Application of capillary electrophoresis-mass spectrometry for the investigation of the binding behavior of oxaliplatin to 5'-GMP in the presence of the sulfur-containing amino acid L-methionine.
Strickmann DB; Kong A; Keppler BK
Electrophoresis; 2002 Jan; 23(1):74-80. PubMed ID: 11824623
[TBL] [Abstract][Full Text] [Related]
13. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
Navarro JA; Salas JM; Romero MA; Vilaplana R; Gonzalez-Vílchez F; Faure R
J Med Chem; 1998 Jan; 41(3):332-8. PubMed ID: 9464364
[TBL] [Abstract][Full Text] [Related]
14. Investigation relevant to the conformation of the 17-membered Pt(d(GpG)) macrocyclic ring formed by Pt anticancer drugs with DNA: Pt complexes with a Goldilocks carrier ligand.
Maheshwari V; Marzilli PA; Marzilli LG
Inorg Chem; 2011 Jul; 50(14):6626-36. PubMed ID: 21667929
[TBL] [Abstract][Full Text] [Related]
15. fac-[Re(CO)3(H2O)3]+ nucleoside monophosphate adducts investigated in aqueous solution by multinuclear NMR spectroscopy.
Adams KM; Marzilli LG
Inorg Chem; 2007 Jun; 46(12):4926-36. PubMed ID: 17506550
[TBL] [Abstract][Full Text] [Related]
16. Modification of second-sphere communication, leading to an unusually high abundance of the head-to-head conformer of cisplatin cross-link retro models.
Saad JS; Scarcia T; Shinozuka K; Natile G; Marzilli LG
Inorg Chem; 2002 Feb; 41(3):546-57. PubMed ID: 11825082
[TBL] [Abstract][Full Text] [Related]
17. Platinum complexes with NH groups on the carrier ligand and with only one guanine or hypoxanthine derivative. Informative models for assessing relative nucleobase and nucleotide hydrogen-bond interactions with amine ligands in solution.
Carlone M; Marzilli LG; Natile G
Inorg Chem; 2004 Jan; 43(2):584-92. PubMed ID: 14731020
[TBL] [Abstract][Full Text] [Related]
18. Thiolate bridging and metal exchange in adducts of a zinc finger model and Pt(II) complexes: biomimetic studies of protein/Pt/DNA interactions.
Almaraz E; de Paula QA; Liu Q; Reibenspies JH; Darensbourg MY; Farrell NP
J Am Chem Soc; 2008 May; 130(19):6272-80. PubMed ID: 18422317
[TBL] [Abstract][Full Text] [Related]
19. Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(mu-carboxylato)dirhodium(II,II).
Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
J Am Chem Soc; 2003 Sep; 125(35):10714-24. PubMed ID: 12940757
[TBL] [Abstract][Full Text] [Related]
20. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
